Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 11
Original Research
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 15,402 | Dovepress* | 14,026+ | 1,795 | 15,821 | |
| PubMed Central* | 1,376 | 479 | 1,855 | ||
| Totals | 15,402 | 2,274 | 17,676 | ||
| *Since 6 June 2019 | |||||
View citations on PubMed Central and Google Scholar